Individuals from multiplex insulin-dependent diabetes mellitus (IDDM) families express higher levels of TCRBV2S1 than controls

被引:5
作者
Craddock, T
Shefta, J
Gilbey, SG
Lancaster, FC
Boylston, AW
机构
[1] Univ Leeds, St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England
[2] St James Univ Hosp, Manny Cussins Clin, Leeds LS9 7TF, W Yorkshire, England
基金
英国惠康基金;
关键词
D O I
10.1016/S0198-8859(97)00232-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T lymphocytes recognise peptide antigens through the T cell antigen receptor, which is composed of variable alpha and beta chains, There are forty-six functional variable regions on the beta chain. In this study the expression of the T cell receptor beta-chain variable regions 2S1 and 3S1, in a large cohort of multiplex insulin-dependent diabetes mellitus families, have been determined by use of monoclonal antibodies and flow cytometry. Peripheral blood was collected from these multiplex families and three control groups, healthy individuals, sporadic insulin-dependent diabetes mellitus patients and non-insulin-dependent diabetes mellitus patients. The level of TCRBV2S1 expression in the multiplex families was significantly higher than all the control groups for both the CD4(+) and CD8(+) T lymphocyte subsets. Detailed analysis of the family data showed that this increased expression was nor associated with age, sex, HLA type or the diabetic phenotype. The TCRBV3S1 expression in all the diabetic cohorts was significantly lower than the healthy controls, in the CD4 subset only. Derailed analysis of the family data showed only the fathers TCRBV3S1 expression was lower than the healthy controls. This study gives further insight into TCRBV usage which could reflect the mechanism of the autoimmune response in IDDM multiplex families. (C) American Society for Histocompatibility and Immunogenetics, 1998. Published by Elsevier Science Inc.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 66 条
[1]   CHARACTERIZATION OF T-CELL REPERTOIRE CHANGES IN ACUTE KAWASAKI-DISEASE [J].
ABE, J ;
KOTZIN, BL ;
MEISSNER, C ;
MELISH, ME ;
TAKAHASHI, M ;
FULTON, D ;
ROMAGNE, F ;
MALISSEN, B ;
LEUNG, DYM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :791-796
[2]  
AKOLKAR PN, 1993, J IMMUNOL, V150, P2761
[3]   PREVENTION OF CYCLOPHOSPHAMIDE-INDUCED DIABETES BY ANTI-V-BETA-8 LYMPHOCYTE-T - RECEPTOR MONOCLONAL-ANTIBODY THERAPY IN NOD WEHI MICE [J].
BACELJ, A ;
CHARLTON, B ;
MANDEL, TE .
DIABETES, 1989, 38 (11) :1492-1495
[4]   MOLECULAR ANALYSIS OF THE T-CELL RECEPTOR V(BETA)5 AND V(BETA)8 REPERTOIRE IN PANCREATIC LESIONS OF AUTOIMMUNE DIABETIC NOD MICE [J].
BERSCHICK, P ;
FEHSEL, K ;
WELTZIEN, HU ;
KOLB, H .
JOURNAL OF AUTOIMMUNITY, 1993, 6 (04) :405-422
[5]   INSITU CHARACTERIZATION OF AUTOIMMUNE PHENOMENA AND EXPRESSION OF HLA MOLECULES IN THE PANCREAS IN DIABETIC INSULITIS [J].
BOTTAZZO, GF ;
DEAN, BM ;
MCNALLY, JM ;
MACKAY, EH ;
SWIFT, PGF ;
GAMBLE, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (06) :353-360
[6]   EVIDENCE FOR AN ENDOGENOUS SUPERANTIGEN DELETING HUMAN V-BETA-2 POSITIVE T-LYMPHOCYTES [J].
BOYLSTON, AW ;
CLARKE, GR ;
LANCASTER, FC ;
REYBURN, H .
T-CELL RECEPTOR USE IN HUMAN AUTOIMMUNE DISEASES, 1995, 756 :113-116
[7]   THE T-CELL RECEPTOR BETA-CHAIN GENES ARE LOCATED ON CHROMOSOME-6 IN MICE AND CHROMOSOME-7 IN HUMANS [J].
CACCIA, N ;
KRONENBERG, M ;
SAXE, D ;
HAARS, R ;
BRUNS, GAP ;
GOVERMAN, J ;
MALISSEN, M ;
WILLARD, H ;
YOSHIKAI, Y ;
SIMON, M ;
HOOD, L ;
MAK, TW .
CELL, 1984, 37 (03) :1091-1099
[8]   ISLET-SPECIFIC T-CELL CLONES FROM NONOBESE DIABETIC MICE EXPRESS HETEROGENEOUS T-CELL RECEPTORS [J].
CANDEIAS, S ;
KATZ, J ;
BENOIST, C ;
MATHIS, D ;
HASKINS, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6167-6170
[9]  
CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243
[10]   BIMODAL DISTRIBUTION OF V-BETA-2(+)CD4(+) T-CELLS IN HUMAN PERIPHERAL-BLOOD [J].
CLARKE, GR ;
REYBURN, H ;
LANCASTER, FC ;
BOYLSTON, AW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) :837-842